http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0011968-A8

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ef4cde335ced957b9320979da60a112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4c47f9c90cd40ecd2a1051904c1bf4c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-175
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-221
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-304
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-305
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
filingDate 1999-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19676cb0eda961085ea1d6dd4b824b44
publicationDate 2000-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0011968-A8
titleOfInvention ANTIOXIDANT COMPOSITION COMPRISING ACETYL L-CARNITINE AND α-LIPOIC ACID
abstract A composition is disclosed which comprises as characterizing active ingredients acetyl L-carnitine and α-lipoic acid, for the prevention and/or therapeutic treatment of various alterations and pathological states induced by free radicals, that may take the form of a dietary supplement, dietetic support or of an actual medicine.
priorityDate 1998-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406934280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226490365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7045767
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226450366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6112

Total number of triples: 42.